Merck & Co. Inc. (MRK) Social Stream
Merck & Co Inc (MRK) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Merck & Co Inc.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 13 | $110 | $79 | $95.272 | $82.4 | 15.62% |
| 2021-11-19 | 13 | $110 | $79 | $94.916 | $82.4 | 15.19% |
| 2021-11-23 | 13 | $110 | $79 | $95.166 | $82.4 | 15.49% |
| 2021-11-29 | 14 | $110 | $79 | $93.692 | $82.4 | 13.7% |
| 2021-12-09 | 16 | $110 | $79 | $93.428 | $82.4 | 13.38% |
| 2021-12-13 | 17 | $110 | $76 | $92.266 | $82.4 | 11.97% |
| 2022-01-24 | 17 | $110 | $70 | $90.875 | $82.4 | 10.29% |
| 2022-02-04 | 17 | $110 | $70 | $90.562 | $82.4 | 9.91% |
| 2022-03-08 | 17 | $110 | $70 | $90.5 | $82.4 | 9.83% |
The Trend in the Analyst Price Target
Over the past 21 months, MRK's average price target has gone down $2.77.
Over the past 48 weeks, MRK's average upside potential has been 21.32%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-01 | 26 | 107 | 80 | 93.110 | 76.87 | 21.13% |
| 2021-09-11 | 26 | 107 | 80 | 93.210 | 73.45 | 26.9% |
| 2021-11-08 | 12 | 110 | 79 | 95.272 | 82.68 | 15.23% |
| 2021-11-19 | 13 | 110 | 79 | 94.916 | 80.70 | 17.62% |
| 2021-12-23 | 17 | 110 | 70 | 90.875 | 75.73 | 20% |
MRK Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.06 | 8 | 0 | 9 | 0 | 0 | 17 |
The Trend in the Broker Recommendations
MRK's average broker recommendation rating improved by 0 over the prior 90 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, Merck & Co Inc's number of analysts covering the stock is greater than 1112.96% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Merck & Co Inc's upside potential (average analyst target price relative to current price) is higher than 92.23% of them.
- In terms of how Merck & Co Inc fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 1103.4% of that group.
- In the context of Pharmaceutical Products stocks, Merck & Co Inc's variance in analysts' estimates is lower than -279.14% of them.
In the Pharmaceutical Products industry, LLY, JNJ, and ABT are the three stocks most similar to Merck & Co Inc regarding the price target and analyst recommendation information presented here.
Is MRK a Buy, Hold or Sell? See the POWR Ratings now!